Author:
Shaker Marcus S.,Oppenheimer John,Wallace Dana V.,Golden David B.K.,Lang David M.,Lang Eddy S.,Bernstein Jonathan A.,Campbell Ronna L.,Chu Derek,Dinakar Chitra,Ellis Anne K.,Greenhawt Matthew,Horner Caroline,Lieberman Jay A.,Rank Matthew A.,Stukus David R.,Wang Julie
Funder
Sanofi
Regeneron
AstraZeneca
Merck
Takeda
CSL Behring
National Institutes of Health
American Academy of Allergy, Asthma, and Immunology
AAAAI
DBV
Novartis
Pfizer
Sandoz
Genentech
Sanofi Genzyme
Asthma and Allergy Foundation of America
GlaxoSmithKline
ACCP
Abbott Nutrition
American Academy of Pediatrics
ESP
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference31 articles.
1. WHO Handbook for Guideline Development,2012
2. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations;Schunemann;CMAJ,2003
3. What is “quality of evidence” and why is it important to clinicians?;Guyatt;BMJ,2008
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献